AVCTF
Price
$1.05
Change
+$0.11 (+11.70%)
Updated
Oct 6 closing price
Capitalization
396.35M
PHMMF
Price
$102.75
Change
-$1.63 (-1.56%)
Updated
Oct 7 closing price
Capitalization
1.75B
Interact to see
Advertisement

AVCTF vs PHMMF

Header iconAVCTF vs PHMMF Comparison
Open Charts AVCTF vs PHMMFBanner chart's image
Avacta Group
Price$1.05
Change+$0.11 (+11.70%)
Volume$9.9K
Capitalization396.35M
Pharma Mar SA
Price$102.75
Change-$1.63 (-1.56%)
Volume$100
Capitalization1.75B
AVCTF vs PHMMF Comparison Chart in %
AVCTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHMMF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AVCTF vs. PHMMF commentary
Oct 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVCTF is a Buy and PHMMF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 09, 2025
Stock price -- (AVCTF: $1.05 vs. PHMMF: $102.75)
Brand notoriety: AVCTF and PHMMF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AVCTF: 252% vs. PHMMF: 2%
Market capitalization -- AVCTF: $396.35M vs. PHMMF: $1.75B
AVCTF [@Biotechnology] is valued at $396.35M. PHMMF’s [@Biotechnology] market capitalization is $1.75B. The market cap for tickers in the [@Biotechnology] industry ranges from $107.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVCTF’s FA Score shows that 0 FA rating(s) are green whilePHMMF’s FA Score has 1 green FA rating(s).

  • AVCTF’s FA Score: 0 green, 5 red.
  • PHMMF’s FA Score: 1 green, 4 red.
According to our system of comparison, PHMMF is a better buy in the long-term than AVCTF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVCTF’s TA Score shows that 4 TA indicator(s) are bullish while PHMMF’s TA Score has 2 bullish TA indicator(s).

  • AVCTF’s TA Score: 4 bullish, 4 bearish.
  • PHMMF’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, AVCTF is a better buy in the short-term than PHMMF.

Price Growth

AVCTF (@Biotechnology) experienced а +40.69% price change this week, while PHMMF (@Biotechnology) price change was +0.49% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.02%. For the same industry, the average monthly price growth was +18.92%, and the average quarterly price growth was +86.47%.

Industries' Descriptions

@Biotechnology (+9.02% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PHMMF($1.75B) has a higher market cap than AVCTF($396M). AVCTF YTD gains are higher at: 85.841 vs. PHMMF (26.742).
AVCTFPHMMFAVCTF / PHMMF
Capitalization396M1.75B23%
EBITDAN/A47.1M-
Gain YTD85.84126.742321%
P/E RatioN/A36.53-
RevenueN/A189M-
Total CashN/A128M-
Total DebtN/A51.4M-
FUNDAMENTALS RATINGS
PHMMF: Fundamental Ratings
PHMMF
OUTLOOK RATING
1..100
93
VALUATION
overvalued / fair valued / undervalued
1..100
2
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
42
PRICE GROWTH RATING
1..100
43
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AVCTFPHMMF
RSI
ODDS (%)
Bearish Trend 2 days ago
57%
Bearish Trend 2 days ago
54%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
57%
Bearish Trend 2 days ago
45%
Momentum
ODDS (%)
Bullish Trend 2 days ago
39%
N/A
MACD
ODDS (%)
Bullish Trend 2 days ago
39%
Bullish Trend 2 days ago
50%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
33%
Bullish Trend 2 days ago
44%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
36%
Bullish Trend 2 days ago
43%
Advances
ODDS (%)
Bullish Trend 3 days ago
50%
N/A
Declines
ODDS (%)
Bearish Trend 28 days ago
30%
Bearish Trend 2 days ago
73%
BollingerBands
ODDS (%)
Bearish Trend 7 days ago
40%
Bearish Trend 2 days ago
21%
Aroon
ODDS (%)
Bullish Trend 2 days ago
25%
Bullish Trend 2 days ago
42%
View a ticker or compare two or three
Interact to see
Advertisement
AVCTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHMMF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DWOIX21.60N/A
N/A
BNY Mellon Research Growth I
CLWFX87.78N/A
N/A
Columbia Cornerstone Growth Inst 2
READX15.56N/A
N/A
Lazard Emerging Markets Eq Advtg R6
LZSMX10.52N/A
N/A
Lazard Global Small Cap Eq Open
HIISX16.47N/A
N/A
Harbor International Small Cap Investor

AVCTF and

Correlation & Price change

A.I.dvisor tells us that AVCTF and KZIA have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AVCTF and KZIA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVCTF
1D Price
Change %
AVCTF100%
N/A
KZIA - AVCTF
26%
Poorly correlated
+0.28%
PHMMF - AVCTF
20%
Poorly correlated
N/A
BETRF - AVCTF
15%
Poorly correlated
+7.53%
AURX - AVCTF
11%
Poorly correlated
N/A
BPMUF - AVCTF
9%
Poorly correlated
N/A
More

PHMMF and

Correlation & Price change

A.I.dvisor indicates that over the last year, PHMMF has been loosely correlated with DRUG. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if PHMMF jumps, then DRUG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PHMMF
1D Price
Change %
PHMMF100%
N/A
DRUG - PHMMF
42%
Loosely correlated
+8.60%
KALV - PHMMF
21%
Poorly correlated
+5.22%
ACAD - PHMMF
21%
Poorly correlated
-1.07%
AVCTF - PHMMF
20%
Poorly correlated
N/A
NURPF - PHMMF
14%
Poorly correlated
N/A
More